A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues

被引:12
|
作者
Suetani, Rachel J. [1 ]
Ho, Kristen [1 ]
Jindal, Shalini [2 ]
Manavis, Jim [3 ]
Neilsen, Paul M. [1 ]
Pishas, Kathleen I. [1 ]
Rippy, Elisabeth [5 ]
Bochner, Melissa [5 ]
Kollias, James [5 ]
Gill, P. Grantley [5 ]
Morris, Howard A. [4 ]
Callen, David F. [1 ]
机构
[1] Univ Adelaide, Ctr Personalised Canc Med, Breast Canc Genet Grp, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Discipline Med, Dame Roma Mitchell Canc Res Lab, Adelaide, SA 5005, Australia
[3] SA Pathol, Ctr Neurol Dis, Adelaide, SA, Australia
[4] SA Pathol, Endocrine Bone Res Lab, Adelaide, SA, Australia
[5] Royal Adelaide Hosp, Breast Endocrine & Surg Oncol Unit, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
Breast cancer; 1,25-Dihydroxyvitamin D; 25-Hydroxyvitamin D; Ex vivo breast tissue; D-RECEPTOR; D PATHWAY; CANCER; EXPRESSION; D-3; GROWTH; CELLS; METABOLISM; CYP27B1; RISK;
D O I
10.1016/j.mce.2012.06.022
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Links between a low vitamin D status and an increased risk of breast cancer have been observed in epidemiological studies. These links have been investigated in human tissue homogenates and cultured cell lines. We have used non-malignant, malignant and normal reduction mammoplasty breast tissues to investigate the biological and metabolic consequences of the application of vitamin D to intact ex vivo human breast tissue. Tissues were exposed to 1 alpha,25(OH)(2)D-3 (1,250; active metabolite) and 25(OH)D (25D; pre-metabolite). Changes in mRNA expression and protein expression after vitamin D exposure were analysed. Results indicate that while responses in normal and non-malignant breast tissues are similar between individuals, different tumour tissues are highly variable with regards to their gene expression and biological response. Collectively, malignant breast tissue responds well to active 1,25D, but not to the inactive pre-metabolite 25D. This may have consequences for the recommendation of vitamin D supplementation in breast cancer patients. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [31] NUCLEASES ADENOSINE DEAMINASE AND DEHYDROGENASES IN MALIGNANT AND NON-MALIGNANT LESIONS OF FEMALE BREAST
    GOLDBERG, DM
    PITTS, JF
    AYRE, HA
    BRITISH JOURNAL OF CANCER, 1967, 21 (02) : 312 - &
  • [32] Effect of green microalgal extracts exhibiting antibacterial activity on viability of human malignant and non-malignant cells
    Senhorinho, Gerusa N. A.
    Lanner, Carita
    Scott, John A.
    PHYCOLOGICAL RESEARCH, 2019, 67 (02) : 145 - 151
  • [33] Non-malignant neutropenia
    Sievers, EL
    Dale, DC
    BLOOD REVIEWS, 1996, 10 (02) : 95 - 100
  • [34] NON-MALIGNANT TUMORS
    COX, JD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (08): : 1129 - 1130
  • [35] Detection of human polyomaviruses MCPyV, HPyV6, and HPyV7 in malignant and non-malignant tonsillar tissues
    Salakova, Martina
    Koslabova, Eva
    Vojtechova, Zuzana
    Tachezy, Ruth
    Sroller, Vojtech
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (04) : 695 - 702
  • [36] Rehabilitation of Persons with Malignant and Non-Malignant Brain Tumours - Comparison of Rehabilitation Outcome
    Grabljevec, Klemen
    BRAIN INJURY, 2019, 33 : 100 - 101
  • [37] Neurological manifestations of malignant and non-malignant dysglobulinaemias
    Steck, AJ
    JOURNAL OF NEUROLOGY, 1998, 245 (10) : 634 - 639
  • [38] Biomarkers and imaging in non-malignant and malignant osteomalacia
    Lüftner, D
    Bollow, M
    Stürzenbecher, A
    Kaufmann, O
    Priem, F
    Richter, A
    Günther, S
    Geppert, R
    Petrides, PE
    Wernecke, KD
    Possinger, K
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2001, 16 (02): : 136 - 141
  • [39] Radium treatment of malignant and non-malignant diseases
    不详
    BRITISH MEDICAL JOURNAL, 1929, 1929 (02): : 551 - 552
  • [40] LEUCOCYTOTOXICITY IN MALIGNANT AND NON-MALIGNANT COLONIC DISEASES
    VOSE, BM
    MOORE, M
    SCHOFIELD, PF
    DYMOCK, IW
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1975, 22 (03): : 393 - 398